Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares.
Eisai Stock Performance
The company has a debt-to-equity ratio of 0.10, a current ratio of 2.20 and a quick ratio of 1.77. The company has a market cap of $17.64 billion, a PE ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31. The business has a fifty day simple moving average of $61.51 and a two-hundred day simple moving average of $61.51.
Eisai Company Profile
Eisai Co, Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines and healthcare products. The company focuses primarily on neuroscience and oncology, with additional products in areas such as neurology, gastrointestinal disorders and preventive healthcare.
Eisai’s marketed medicines include Leqembi (lecanemab), an Alzheimer’s disease treatment developed in collaboration with Biogen; Dayvigo for insomnia; Fycompa for epilepsy; and Halaven for certain cancers.
Read More
- Five stocks we like better than Eisai
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
